vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Globalstar, Inc. (GSAT). Click either name above to swap in a different company.
Globalstar, Inc. is the larger business by last-quarter revenue ($72.0M vs $62.1M, roughly 1.2× Cytek Biosciences, Inc.). Globalstar, Inc. runs the higher net margin — -16.1% vs -70.9%, a 54.8% gap on every dollar of revenue. On growth, Globalstar, Inc. posted the faster year-over-year revenue change (17.6% vs 8.1%). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 12.9%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Globalstar, Inc. is an American telecommunications company that operates a satellite constellation in low Earth orbit (LEO) for satellite phone, low-speed data transmission and Earth observation. The Globalstar second-generation constellation consists of 25 satellites.
CTKB vs GSAT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $72.0M |
| Net Profit | $-44.1M | $-11.6M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | -0.5% |
| Net Margin | -70.9% | -16.1% |
| Revenue YoY | 8.1% | 17.6% |
| Net Profit YoY | -557.1% | 76.9% |
| EPS (diluted) | — | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $72.0M | ||
| Q3 25 | $52.3M | $73.8M | ||
| Q2 25 | $45.6M | $67.1M | ||
| Q1 25 | $41.5M | $60.0M | ||
| Q4 24 | $57.5M | $61.2M | ||
| Q3 24 | $51.5M | $72.3M | ||
| Q2 24 | $46.6M | $60.4M | ||
| Q1 24 | $44.9M | $56.5M |
| Q4 25 | $-44.1M | $-11.6M | ||
| Q3 25 | $-5.5M | $1.1M | ||
| Q2 25 | $-5.6M | $19.2M | ||
| Q1 25 | $-11.4M | $-17.3M | ||
| Q4 24 | $9.6M | $-50.2M | ||
| Q3 24 | $941.0K | $9.9M | ||
| Q2 24 | $-10.4M | $-9.7M | ||
| Q1 24 | $-6.2M | $-13.2M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | -0.5% | ||
| Q3 25 | -17.6% | 13.8% | ||
| Q2 25 | -23.3% | 9.2% | ||
| Q1 25 | -36.1% | -14.2% | ||
| Q4 24 | 5.2% | -6.9% | ||
| Q3 24 | -8.2% | 13.0% | ||
| Q2 24 | -18.3% | -2.4% | ||
| Q1 24 | -23.9% | -8.3% |
| Q4 25 | -70.9% | -16.1% | ||
| Q3 25 | -10.5% | 1.5% | ||
| Q2 25 | -12.2% | 28.6% | ||
| Q1 25 | -27.5% | -28.9% | ||
| Q4 24 | 16.8% | -82.1% | ||
| Q3 24 | 1.8% | 13.7% | ||
| Q2 24 | -22.4% | -16.0% | ||
| Q1 24 | -13.8% | -23.4% |
| Q4 25 | — | $-0.11 | ||
| Q3 25 | — | $-0.01 | ||
| Q2 25 | — | $0.13 | ||
| Q1 25 | — | $-0.16 | ||
| Q4 24 | — | $-0.57 | ||
| Q3 24 | — | $0.00 | ||
| Q2 24 | — | $-0.01 | ||
| Q1 24 | — | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $447.5M |
| Total DebtLower is stronger | — | $483.8M |
| Stockholders' EquityBook value | $341.7M | $355.7M |
| Total Assets | $461.5M | $2.3B |
| Debt / EquityLower = less leverage | — | 1.36× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $447.5M | ||
| Q3 25 | $93.3M | $346.3M | ||
| Q2 25 | $75.5M | $308.2M | ||
| Q1 25 | $95.3M | $241.4M | ||
| Q4 24 | $98.7M | $391.2M | ||
| Q3 24 | $162.3M | $51.9M | ||
| Q2 24 | $177.9M | $64.3M | ||
| Q1 24 | $168.8M | $59.3M |
| Q4 25 | — | $483.8M | ||
| Q3 25 | — | $508.6M | ||
| Q2 25 | — | $491.5M | ||
| Q1 25 | — | $502.7M | ||
| Q4 24 | — | $511.4M | ||
| Q3 24 | — | $394.4M | ||
| Q2 24 | — | $393.1M | ||
| Q1 24 | — | $398.7M |
| Q4 25 | $341.7M | $355.7M | ||
| Q3 25 | $378.6M | $364.8M | ||
| Q2 25 | $377.6M | $360.9M | ||
| Q1 25 | $379.6M | $344.3M | ||
| Q4 24 | $395.7M | $358.9M | ||
| Q3 24 | $385.5M | $394.1M | ||
| Q2 24 | $389.1M | $383.0M | ||
| Q1 24 | $392.6M | $377.1M |
| Q4 25 | $461.5M | $2.3B | ||
| Q3 25 | $494.9M | $2.2B | ||
| Q2 25 | $493.3M | $1.9B | ||
| Q1 25 | $482.6M | $1.7B | ||
| Q4 24 | $499.5M | $1.7B | ||
| Q3 24 | $491.2M | $917.6M | ||
| Q2 24 | $483.7M | $926.2M | ||
| Q1 24 | $492.1M | $917.0M |
| Q4 25 | — | 1.36× | ||
| Q3 25 | — | 1.39× | ||
| Q2 25 | — | 1.36× | ||
| Q1 25 | — | 1.46× | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 1.03× | ||
| Q1 24 | — | 1.06× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $175.9M |
| Free Cash FlowOCF − Capex | $-1.8M | — |
| FCF MarginFCF / Revenue | -2.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $175.9M | ||
| Q3 25 | $-3.9M | $236.0M | ||
| Q2 25 | $108.0K | $157.9M | ||
| Q1 25 | $-125.0K | $51.9M | ||
| Q4 24 | $2.0M | $340.7M | ||
| Q3 24 | $13.2M | $32.0M | ||
| Q2 24 | $6.2M | $36.7M | ||
| Q1 24 | $4.0M | $29.8M |
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-974.0K | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $3.4M | — |
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | — | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 23.7% | — | ||
| Q2 24 | 11.0% | — | ||
| Q1 24 | 7.6% | — |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 1.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 216.53× | ||
| Q2 25 | — | 8.22× | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | 3.23× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
GSAT
| Services | $67.4M | 94% |
| Products | $4.6M | 6% |
